ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
229.94
-22.89 (-9.05%)
At close: Oct 30, 2026, 4:00 PM EDT
230.00
+0.06 (0.03%)
After-hours: Oct 30, 2026, 7:56 PM EDT

ResMed Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Quarter
Q1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
1,4151,4641,4311,4231,3361,3481,2921,2821,2251,2231,1971,1631,1021,1221,1171,034950.29914.74864.5894.87
Revenue Growth (YoY)
5.93%8.58%10.81%10.98%9.07%10.20%7.92%10.26%11.09%9.01%7.17%12.48%16.00%22.66%29.20%15.52%5.12%4.41%12.45%11.86%
Cost of Revenue
536.25594.13532.58536.28506.94518.56517.88523.18499.62499.68496.39507.61493.35496.28490.82446.72403.11385.85362.32379.33
Gross Profit
878.57869.52898.83886.53828.64829.44773.85758.91724.89723.51700.59655.19608.97625.78626.07587.02547.18528.89502.18515.55
Selling, General & Admin
294.72293.36279.8275.7259.19265.13245.3241.61238.98242.19229.92222.16222.87240.69228.46211.67193.93193.03182.4185.36
Research & Development
101.86105.7394.2790.9787.3286.4483.9481.3779.5280.8677.0773.8875.7178.1476.4469.8763.1964.3266.862.51
Amortization of Goodwill & Intangibles
-18.819.119.5719.7821.318.3418.6819.0719.2519.0219.8321.3920.7120.5116.8714.3214.2818.7118.97
Operating Expenses
396.58417.88393.16386.24366.29372.87347.59341.67337.58342.3326.01315.87319.97339.54325.4298.41271.45271.62267.91266.84
Operating Income
481.98451.64505.67500.3462.35456.57426.27417.24387.31381.22374.58339.32289286.24300.67288.61275.74257.26234.27248.71
Interest Expense
-------2.07-3.66-4.43-2.21-13.44-16.1-17.97-18.7-14.96-12.46-7.13-5.54-5.46-5.95
Interest & Investment Income
16.3831.763.84.464.699.57--------------
Earnings From Equity Investments
1.882.231.721.521.491.270.341.080.960.870.440.74-3.9-2.23-0.18-2.83-2.03-2.56-2.63-1.91
Currency Exchange Gain (Loss)
--13.956.93-1.830.24-4.76-1.263.310.32-6.6-0.641.513.01-0.45-2.13-2.81--
Other Non Operating Income (Expenses)
0.44.40.180.040.03-0.040.071.790.01-0.070.560.12.654.27-2.56-1.71-1.5-0.341.880.84
EBT Excluding Unusual Items
500.65476.09518.3504.48468.79462.62423.34419.76384.18373.21361.5325.57272.79269.13282.96273.74265.07251.63228.05241.69
Merger & Restructuring Charges
-29-5.63-5.86-5.94-15.81-2.03------64.23--10.97--8.41--1.86--
Gain (Loss) on Sale of Investments
5.721-10.130.31-6.19-2.53-5.65-1.44-0.68-15.4713.92-1.89-0.6-1.586.428.37-3.28-11.68-1.74-4.4
Gain (Loss) on Sale of Assets
61.78-------------------
Asset Writedown
-2.7--2.7----------------
Pretax Income
539.16474.16502.31496.15446.79458.05417.69418.32383.5357.73375.42259.45272.19276.8289.38273.69261.79238.09226.32237.29
Income Tax Expense
120.7490.73103.58103.5698.2678.3552.6573.772.1465.574.9350.6552.7747.1456.8848.7851.3243.0347.3135.54
Net Income
418.41383.43398.73392.59348.54379.71365.04344.62311.36292.24300.49208.8219.42229.66232.5224.91210.48195.06179.01201.75
Net Income to Common
418.41383.43398.73392.59348.54379.71365.04344.62311.36292.24300.49208.8219.42229.66232.5224.91210.48195.06179.01201.75
Net Income Growth (YoY)
20.05%0.98%9.23%13.92%11.94%29.93%21.48%65.05%41.90%27.25%29.24%-7.17%4.25%17.74%29.88%11.48%3.37%-0.02%-12.39%
Shares Outstanding (Basic)
143145145146146146147147147147147147147147147147146146146146
Shares Outstanding (Diluted)
143145146146147147147147148148147148147148147147147147147147
Shares Change (YoY)
-2.37%-1.40%-1.02%-0.75%-0.47%-0.34%-0.16%-0.04%0.08%-0.01%0.04%0.10%0.24%0.38%0.29%0.25%0.19%0.31%1.00%0.42%
EPS (Basic)
2.932.652.742.692.382.592.492.352.121.992.041.421.491.561.581.531.441.331.221.38
EPS (Diluted)
2.922.642.742.682.372.582.482.342.111.982.041.421.491.561.581.531.431.331.221.37
EPS Growth (YoY)
23.21%2.39%10.48%14.53%12.32%30.34%21.57%64.89%41.61%26.89%29.11%-7.25%4.20%17.29%29.51%11.68%2.88%0.06%-11.38%

Additional Metrics

Fiscal Quarter
Q1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
373.68403.5520.48311.21414.36508.18557.87287.98307.7415.23380.84249.48256.25202.99253.75101.2915.6150.8468.99189.47
Free Cash Flow Per Share
2.612.783.572.132.823.463.791.952.082.812.581.691.741.381.720.690.110.350.471.29
Dividend Per Share
0.6600.6000.6000.6000.6000.5300.5300.5300.5300.4800.4800.4800.4800.4400.4400.4400.4400.4200.4200.420
Dividend Growth (YoY)
10.00%13.21%13.21%13.21%13.21%10.42%10.42%10.42%10.42%9.09%9.09%9.09%9.09%4.76%4.76%4.76%4.76%0%7.69%7.69%
Gross Margin
62.10%59.41%62.79%62.31%62.04%61.53%59.91%59.19%59.20%59.15%58.53%56.35%55.24%55.77%56.05%56.79%57.58%57.82%58.09%57.61%
Operating Margin
34.07%30.86%35.33%35.16%34.62%33.87%33.00%32.54%31.63%31.17%31.29%29.18%26.22%25.51%26.92%27.92%29.02%28.12%27.10%27.79%
Profit Margin
29.57%26.20%27.86%27.59%26.10%28.17%28.26%26.88%25.43%23.89%25.10%17.96%19.91%20.47%20.82%21.76%22.15%21.32%20.71%22.55%
Free Cash Flow Margin
26.41%27.57%36.36%21.87%31.02%37.70%43.19%22.46%25.13%33.95%31.82%21.45%23.25%18.09%22.72%9.80%1.64%5.56%7.98%21.17%
EBITDA
523.73490.13558.22543.79503.64513.86463.68457.28425.58418.13411.3377.17326.94326338.07320.41306.87289.36266.66279.34
EBITDA Margin
37.02%33.49%39.00%38.22%37.71%38.12%35.90%35.67%34.76%34.18%34.36%32.44%29.66%29.05%30.27%31.00%32.29%31.63%30.85%31.22%
D&A For EBITDA
41.7438.4952.5543.4941.357.2837.4140.0438.2736.9136.7237.8537.9439.7737.431.8131.1332.0932.430.63
EBIT
481.98451.64505.67500.3462.35456.57426.27417.24387.31381.22374.58339.32289286.24300.67288.61275.74257.26234.27248.71
EBIT Margin
34.07%30.86%35.33%35.16%34.62%33.87%33.00%32.54%31.63%31.17%31.29%29.18%26.22%25.51%26.92%27.92%29.02%28.12%27.10%27.79%
Effective Tax Rate
22.39%19.13%20.62%20.87%21.99%17.11%12.61%17.62%18.81%18.31%19.96%19.52%19.39%17.03%19.66%17.82%19.60%18.07%20.90%14.98%
Revenue as Reported
-1,4641,4311,4231,3361,3481,2921,2821,2251,2231,1971,1631,1021,1221,1171,034950.29914.74864.5894.87
SEC Filings: 10-K · 10-Q